Wet autoclave pretreatment improves the visualization of silver-stained nucleolar organizer-region-associated proteins in routinely formalin-fixed and paraffin-embedded tissues.

PubWeight™: 1.18‹?› | Rank: Top 10%

🔗 View Article (PMID 7892164)

Published in Mod Pathol on December 01, 1994

Authors

D Ofner1, A Bankfalvi, K Riehemann, B Bier, W Böcker, K W Schmid

Author Affiliations

1: Gerhard-Domagk Institute of Pathology, University of Münster, Germany.

Articles by these authors

[Recommendations and unanswered questions in the diagnosis and treatment of thyroid nodules. Opinion of the Thyroid Section of the German Society for Endocrinology]. Dtsch Med Wochenschr (2005) 2.45

Surgical cure for early rectal carcinomas (T1). Transanal endoscopic microsurgery vs. anterior resection. Dis Colon Rectum (1996) 2.34

Characterization of breast carcinomas by two monoclonal antibodies distinguishing myoepithelial from luminal epithelial cells. J Histochem Cytochem (1986) 2.05

Wet autoclave pretreatment for antigen retrieval in diagnostic immunohistochemistry. J Pathol (1994) 1.88

Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys (2000) 1.72

Expression of neural BC200 RNA in human tumours. J Pathol (1997) 1.70

A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol Cell (2000) 1.64

Is fine-needle aspiration of tumours harmless? Lancet (1989) 1.55

Murine leukocytes with ring-shaped nuclei include granulocytes, monocytes, and their precursors. J Leukoc Biol (1999) 1.53

Possible role of tissue-bound calcium ions in citrate-mediated high-temperature antigen retrieval. J Pathol (1994) 1.52

Desmoplasia in medullary thyroid carcinoma: a reliable indicator of metastatic potential. Histopathology (2008) 1.51

Regulation of NF-kappa B activation by MAP kinase cascades. Immunobiology (1997) 1.50

Malignant hemangioendothelioma of the thyroid. Its immunohistochemical discrimination from undifferentiated thyroid carcinoma. Am J Surg Pathol (1990) 1.46

Potential embolization by atherosclerotic debris dislodged from aortic wall during cardiac catheterization:: histological and clinical findings in 7,621 patients. Catheter Cardiovasc Interv (2000) 1.45

Diffuse sclerosing variant of papillary thyroid carcinoma. S-100 protein immunocytochemistry and prognosis. Virchows Arch A Pathol Anat Histopathol (1990) 1.40

Life history of cutaneous vascular lesions in Sneddon's syndrome. Hum Pathol (1992) 1.39

Cholangiofibromatosis associated with portal hypertension. Am J Gastroenterol (1994) 1.39

[Current status of grading in breast cancer]. Pathologe (1992) 1.38

Identification of mycobacteria to the species level by automated restriction enzyme fragment length polymorphism analysis. Virchows Arch (1995) 1.36

Erdheim-Chester disease: case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literature. J Clin Pathol (2004) 1.34

Genetic relation of lobular carcinoma in situ, ductal carcinoma in situ, and associated invasive carcinoma of the breast. Mol Pathol (2000) 1.34

Chromosomal aberrations associated with invasion in papillary superficial bladder cancer. J Pathol (1998) 1.31

Differential expression of annexins I, II and IV in human tissues: an immunohistochemical study. Histochem Cell Biol (1998) 1.26

Analysis of deregulated miRNAs is helpful to distinguish poorly differentiated thyroid carcinoma from papillary thyroid carcinoma. Horm Metab Res (2009) 1.26

Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44. Histopathology (1999) 1.25

Immunohistochemical distribution and serum levels of the Ca(2+)-binding proteins MRP8, MRP14 and their heterodimeric form MRP8/14 in Crohn's disease. Digestion (1995) 1.25

Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival. Br J Cancer (1995) 1.22

Differential miRNA expression profiles in variants of papillary thyroid carcinoma and encapsulated follicular thyroid tumours. Br J Cancer (2009) 1.21

Cytogenetic analysis of multifocal bladder cancer supports a monoclonal origin and intraepithelial spread of tumor cells. Cancer Res (2001) 1.19

[Papillary tumors of the breast]. Pathologe (2006) 1.16

Gains and losses of CD44 expression during breast carcinogenesis and tumour progression. Histopathology (1998) 1.15

Tumors of the papilla of Vater--inadequate diagnostic impact of endoscopic forceps biopsies taken prior to and following sphincterotomy. Ann Oncol (1999) 1.15

Different variants of frontotemporal dementia: a neuropathological and immunohistochemical study. Acta Neuropathol (1996) 1.13

Comparative coronary anatomy in six twin pairs with coronary artery disease. Heart (2000) 1.11

An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ. Virchows Arch A Pathol Anat Histopathol (1992) 1.11

AKT and ERK1/2 signaling in intrahepatic cholangiocarcinoma. World J Gastroenterol (2007) 1.10

Immigrating progenitor cells contribute to human podocyte turnover. Kidney Int (2007) 1.07

Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours. J Clin Pathol (2011) 1.07

Lipomatous lesions of the thyroid gland: a review. Appl Pathol (1985) 1.07

Transepithelial transport processes at the intestinal mucosa in inflammatory bowel disease. Int J Colorectal Dis (1999) 1.06

Site preference of metastatic tumours of the brain. Virchows Arch A Pathol Anat Histopathol (1988) 1.06

Interdisciplinary consensus on the use and technique of vacuum-assisted stereotactic breast biopsy. Eur J Radiol (2003) 1.06

Expression and complex formation of S100-like proteins MRP8 and MRP14 by macrophages during renal allograft rejection. Transplantation (1994) 1.04

Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Advantages of a low-dose nonsteroidal anti-inflammatory drug regimen in reversing adenomas exceeding 33 months. Dis Colon Rectum (1995) 1.04

The myeloic related protein MRP8/14 (27E10 antigen)--usefulness as a potential marker for disease activity in ulcerative colitis and putative biological function. Eur J Clin Invest (1995) 1.03

Immunohistochemically demonstrated metallothionein expression in malignant melanoma. Histopathology (1993) 1.02

Deep penetrating dermatofibroma versus dermatofibrosarcoma protuberans. A clinicopathologic comparison. Am J Surg Pathol (1994) 1.02

Activation of extracellular regulated kinases (ERK1/2) but not AKT predicts poor prognosis in colorectal carcinoma and is associated with k-ras mutations. Virchows Arch (2007) 1.01

Establishment of immortalized periodontal ligament progenitor cell line and its behavioural analysis on smooth and rough titanium surface. Eur Cell Mater (2010) 1.00

Diagnostic value of different PCR assays for the detection of mycobacterial DNA in granulomatous lymphadenopathy. J Pathol (1996) 1.00

An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I: Normal breast and benign proliferative lesions. Virchows Arch A Pathol Anat Histopathol (1992) 0.99

Prognostic value of histobiological factors (malignancy grading and AgNOR content) assessed at the invasive tumour front of oral squamous cell carcinomas. Br J Cancer (1997) 0.99

Chromogranins A and B are co-localized with atrial natriuretic peptides in secretory granules of rat heart. J Histochem Cytochem (1990) 0.98

Prognostic value of graph theory-based tissue architecture analysis in carcinomas of the tongue. Lab Invest (2000) 0.98

Expression patterns of angiogenic and lymphangiogenic factors in ductal breast carcinoma in situ. Br J Cancer (2005) 0.98

The invasive front of carcinomas. The most important area for tumour prognosis? Anticancer Res (1999) 0.98

Targeting of Rad51-dependent homologous recombination: implications for the radiation sensitivity of human lung cancer cell lines. Br J Cancer (2005) 0.98

Significance of metallothionein overexpression in human tumours. Histopathology (1997) 0.97

Secretory meningioma: clinical, histologic, and immunohistochemical findings in 31 cases. Cancer (1997) 0.97

Calcitonin screening and pentagastrin testing: predictive value for the diagnosis of medullary carcinoma in nodular thyroid disease. Eur J Endocrinol (2010) 0.97

The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma. Ann Oncol (2009) 0.97

Gastric stump cancer: etiopathological and clinical aspects. Endoscopy (1989) 0.97

A fourteen year practice with the fine needle aspiration biopsy of the thyroid in an endemic area. Pathol Res Pract (1986) 0.96

Chromogranin A, B, and C in human adrenal medulla and endocrine tissues. Lab Invest (1986) 0.96

Endoscopic treatment of large primary adrenal tumours. Br J Surg (2005) 0.96

Prognostic factors in medullary thyroid carcinomas. Survival in relation to age, sex, stage, histology, immunocytochemistry, and DNA content. Cancer (1988) 0.96

Lack of correlation between BRAF V600E mutational status and the expression profile of a distinct set of miRNAs in papillary thyroid carcinoma. Horm Metab Res (2009) 0.96

Exulceratio simplex Dieulafoy of the colon--a case report. Endoscopy (1988) 0.95

Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis. Dis Colon Rectum (1997) 0.95

Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours. Virchows Arch (1994) 0.95

The vascularization of liver metastases. Histological investigation of gelatine-injected liver specimens with special regard to the vascularization of micrometastases. J Cancer Res Clin Oncol (1988) 0.94

Micronuclei-biological indicator for retrospective dosimetry after exposure to ionizing radiation. Mutat Res (1998) 0.94

Clonal overexpression of metallothionein is induced by somatic mutation in morphologically normal colonic mucosa. J Pathol (1998) 0.93

Epidermal growth factor receptor as a novel therapeutic target in anaplastic thyroid carcinomas. Ann N Y Acad Sci (2004) 0.93

Oncogenic RAS simultaneously protects against anti-EGFR antibody-dependent cellular cytotoxicity and EGFR signaling blockade. Oncogene (2012) 0.92

Rapid detection of loss of heterozygosity of chromosome 17p by polymerase chain reaction-based variable number of tandem repeat analysis and detection of single-strand conformation polymorphism of intragenic p53 polymorphisms. Virchows Arch (1994) 0.92

[Inflammatory diseases of the thyroid gland. Epidemiology, symptoms and morphology]. Pathologe (2003) 0.92

[Acute thoracic aortic dissection with occlusion of the left coronary artery]. Herz (1997) 0.91

p53 abnormalities are rare events in neuroendocrine (Merkel cell) carcinoma of the skin. An immunohistochemical and SSCP analysis. Virchows Arch (1997) 0.91

Relationship between quantity of silver stained nucleolar organizer regions associated proteins (Ag-NORs) and population doubling time in ten breast cancer cell lines. Pathol Res Pract (1992) 0.91

Clear-cell carcinomas of thyroid gland: a clinicopathological study of 13 cases. Histopathology (1986) 0.91

Attitude of health care professionals to organ donation: two surveys among the staff of a German university hospital. Transplant Proc (2010) 0.90

Immunohistochemical demonstration of metallothionein in normal human breast tissue and benign and malignant breast lesions. Breast Cancer Res Treat (1994) 0.90

Silver stained nucleolar organizer region proteins (Ag-NORs) as a predictor of prognosis in colonic cancer. J Pathol (1990) 0.90

Metallothionein expression in duct carcinoma in situ of the breast. Hum Pathol (1995) 0.89

Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease. Arterioscler Thromb Vasc Biol (1995) 0.89